A detailed history of Dfpg Investments, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Dfpg Investments, LLC holds 18,254 shares of CTLT stock, worth $1.03 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
18,254
Previous 15,734 16.02%
Holding current value
$1.03 Million
Previous $716,000 14.53%
% of portfolio
0.06%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 09, 2024

BUY
$32.18 - $46.57 $81,093 - $117,356
2,520 Added 16.02%
18,254 $820,000
Q3 2023

Nov 13, 2023

BUY
$44.2 - $50.2 $188,159 - $213,701
4,257 Added 37.09%
15,734 $716,000
Q2 2023

Jul 24, 2023

BUY
$31.86 - $67.26 $62,350 - $131,627
1,957 Added 20.56%
11,477 $497,000
Q1 2023

Apr 10, 2023

BUY
$45.44 - $74.26 $74,930 - $122,454
1,649 Added 20.95%
9,520 $625,000
Q4 2022

Feb 02, 2023

BUY
$41.39 - $81.0 $325,780 - $637,551
7,871 New
7,871 $354,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.1B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Dfpg Investments, LLC Portfolio

Follow Dfpg Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dfpg Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dfpg Investments, LLC with notifications on news.